EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Occupational Laboratory Exposures to Burkholderia pseudomallei in the United States: A Review of Exposures and Serological Monitoring Data, 2008–2024

Brian T Richardson iD, Mindy G Elrod iD, Katherine M DeBord iD, Caroline A Schrodt iD, Julie M Thompson iD, Tina J Benoit iD, Lindy Liu iD, Julia K Petras iD, David Blaney iD, Jay E Gee iD, Vit Kraushaar iD, Danielle Stanek iD und 12 weitere

Pathogens · 2025

DOI: 10.3390/pathogens14090897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Brian T Richardson und 23 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Hauptthemen laut MEDLINE: Burkholderia pseudomallei, Melioidosis, Occupational Exposure. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centers for Disease Control and Prevention Emerging Infectious Disease funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with Burkholderia pseudomallei, the causative agent of melioidosis, is uncommon in the United States (U.S.), leading to delays in pathogen identification and clinical diagnosis which can often lead to laboratory exposures. The indirect hemagglutination assay (IHA) is the primary serological test for confirming exposure to B. pseudomallei. In the U.S., a titer of ≥1:40 suggests exposure to B. pseudomallei or a closely related species, and a 4-fold rise in IHA titer ≥1:40 with clinically compatible illness is considered diagnostically probable. A retrospective analysis of 160 voluntarily reported laboratory exposure events to B. pseudomallei across 29 U.S. jurisdictions and 5 countries between 2008–2024 was conducted. This analysis included post-exposure management data and IHA results for 855 exposed laboratory personnel who had serological monitoring performed at the U.S. Centers for Disease Control and Prevention (CDC). Among exposed laboratory personnel, 105 (12%) had a seropositive titer. Of these, ninety-one (87%) laboratory personnel remained seropositive (≥1:40) at their last IHA test. Five (1%) people had a 4-fold rise in titers, though none developed melioidosis. This report underscores the need for prospective studies to evaluate seropositive laboratory personnel and to update risk guidance for laboratory exposures in non-endemic areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkholderia pseudomalleiMelioidosisOccupational ExposureHumansUnited StatesRetrospective StudiesAntibodies, BacterialMaleFemaleMiddle AgedAdultHemagglutination TestsSerologic Tests

Stichwörter der Autor:innen

Burkholderia pseudomalleiindirect hemagglutination assaylaboratory exposuremelioidosisseroconversionserology

Substanzen

Antibodies, Bacterial

Autor:innen und Institutionen

  • National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
  • Epidemic Intelligence Service, CDC, Atlanta, GA 30329, USA.
  • California Department of Public Health, Sacramento, CA 95814, USA.
  • Florida Department of Health, Tallahassee, FL 32311, USA.
  • Virginia Department of Health, Richmond, VA 23219, USA.
  • Career Epidemiology Field Officer Program, Division of State and Local Readiness, Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

ORCID-Profile: Brian T Richardson, Mindy G Elrod, Katherine M DeBord, Caroline A Schrodt, Julie M Thompson, Tina J Benoit, Lindy Liu, Julia K Petras, David Blaney, Jay E Gee, Vit Kraushaar, Danielle Stanek, Katie M Kurkjian, LaToya Griffin-Thomas, W Gina Pang, Kristin Garafalo, Maria Bye, Christina Egan, Maria E Negron, William A Bower, Alex R Hoffmaster, Zachary P Weiner, Caitlin M Cossaboom

Förderung

  • Centers for Disease Control and Prevention Emerging Infectious Disease funds

Zitieren

APA

Richardson, B. T., Elrod, M. G., DeBord, K. M., Schrodt, C. A., Thompson, J. M., Benoit, T. J., Liu, L., Petras, J. K., Blaney, D., Gee, J. E., Kraushaar, V., Stanek, D., Kurkjian, K. M., Griffin-Thomas, L., Pang, W. G., Garafalo, K., Brown, C. M., Bye, M., Egan, C., …, & Cossaboom, C. M. (2025). Occupational Laboratory Exposures to Burkholderia pseudomallei in the United States: A Review of Exposures and Serological Monitoring Data, 2008–2024. Pathogens. https://doi.org/10.3390/pathogens14090897

Vancouver

Richardson BT, Elrod MG, DeBord KM, Schrodt CA, Thompson JM, Benoit TJ, et al. Occupational Laboratory Exposures to Burkholderia pseudomallei in the United States: A Review of Exposures and Serological Monitoring Data, 2008–2024. Pathogens. 2025. doi:10.3390/pathogens14090897

BibTeX
@article{Richardson2025,
  author = {Richardson, Brian T and Elrod, Mindy G and DeBord, Katherine M and Schrodt, Caroline A and Thompson, Julie M and Benoit, Tina J and Liu, Lindy and Petras, Julia K and Blaney, David and Gee, Jay E and Kraushaar, Vit and Stanek, Danielle and Kurkjian, Katie M and Griffin-Thomas, LaToya and Pang, W Gina and Garafalo, Kristin and Brown, Catherine M and Bye, Maria and Egan, Christina and Negron, Maria E and Bower, William A and Hoffmaster, Alex R and Weiner, Zachary P and Cossaboom, Caitlin M},
  title = {Occupational Laboratory Exposures to Burkholderia pseudomallei in the United States: A Review of Exposures and Serological Monitoring Data, 2008–2024},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14090897}
}
Kostenlos starten →